[Multidisciplinary position paper on the management of patent foramen ovale in the presence of cryptogenic cerebral ischemia - Italian version 2013].

There is no generally accepted consensus on the management of patent foramen ovale (PFO) in the presence of cryptogenic cerebral ischemia, because of the lack of conclusive evidence. The aim of this position paper was to develop and promote a joint approach based on available data that may be shared by different specialists, while waiting for definite results from randomized controlled trials. A position statement was produced involving the major national scientific societies. The task force members were nominated by the presidents and/or executive boards of each society or working group, as appropriate, based on their previous work in relevant topic areas. Specific task force working groups prepared the drafts. In order to achieve maximum agreement, these drafts were merged and distributed to the scientific societies for local evaluation. The ensuing final draft, merging all the revisions, was reviewed by the task force and finally approved by all scientific societies. The following issues were addressed: definitions of transient ischemic attack (TIA) and both symptomatic and asymptomatic cryptogenic stroke; formulation of a diagnostic workup for patients with clinical event(s) and PFO; recommendations regarding medical and interventional treatment options considering individual risk factors based on the three available randomized trials and other observational studies; recommendations regarding requirements for operators and centers in Italy; definition of a follow-up evaluation protocol. In conclusion, available data provided the basis for the first multi-society position paper on the management of cryptogenic stroke/TIA and PFO.

[1]  I. Palacios,et al.  Patent foramen ovale transcatheter closure vs. medical therapy on recurrent vascular events: a systematic review and meta-analysis of randomized controlled trials. , 2013, European heart journal.

[2]  G. Anzola,et al.  PEDIATRIC AND CONGENITAL HEART DISEASE Original Studies Management of Patients with Patent Foramen Ovale and Cryptogenic Stroke: A Collaborative, Multidisciplinary, Position Paper , 2013 .

[3]  D. Kent,et al.  Still no closure on the question of PFO closure. , 2013, The New England journal of medicine.

[4]  J. Carroll,et al.  Closure of patent foramen ovale versus medical therapy after cryptogenic stroke. , 2013, The New England journal of medicine.

[5]  G. Schuler,et al.  Percutaneous closure of patent foramen ovale in cryptogenic embolism. , 2013, The New England journal of medicine.

[6]  R. Felberg,et al.  Closure or medical therapy for cryptogenic stroke with patent foramen ovale. , 2012, The New England journal of medicine.

[7]  W. Ghali,et al.  Recurrent cerebral ischemia in medically treated patent foramen ovale: A meta-analysis , 2011, Neurology.

[8]  S. Cook,et al.  Figulla PFO occluder versus Amplatzer PFO occluder for percutaneous closure of patent foramen ovale , 2011, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[9]  M. Tatagiba,et al.  Genetics of Moyamoya disease , 2010, Journal of Human Genetics.

[10]  G. Anzola,et al.  Patent foramen ovale (PFO) and cryptogenic stroke , 2010, Journal of thrombosis and haemostasis : JTH.

[11]  P. Colonna,et al.  Recommendations for echocardiography use in the diagnosis and management of cardiac sources of embolism: European Association of Echocardiography (EAE) (a registered branch of the ESC). , 2010, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[12]  G. Rigatelli,et al.  Patent oval foramen transcatheter closure: results of a strategy based on tailoring the device to the specific patient’s anatomy , 2010, Cardiology in the Young.

[13]  P. Gorelick,et al.  Inherited metabolic disorders and stroke part 2: homocystinuria, organic acidurias, and urea cycle disorders. , 2010, Archives of neurology.

[14]  D. Kozel,et al.  Transthoracic second harmonic two- and three-dimensional echocardiography for detection of patent foramen ovale. , 2010, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[15]  F. Viader,et al.  Silent Cerebral Infarcts in Patients With Pulmonary Embolism and a Patent Foramen Ovale: A Prospective Diffusion-Weighted MRI Study , 2009, Stroke.

[16]  B. Hemmer,et al.  Lesion patterns in patients with cryptogenic stroke with and without right‐to‐left‐shunt , 2009, European journal of neurology.

[17]  A. Gaspardone,et al.  Usefulness of transcatheter patent foramen ovale closure in migraineurs with moderate to large right-to-left shunt and instrumental evidence of cerebrovascular damage. , 2009, The American journal of cardiology.

[18]  K. Whitehead,et al.  Unusual Presentation of Nickel Allergy Requiring Explantation of an Amplatzer Atrial Septal Occluder Device , 2009, Clinical cardiology.

[19]  D. Kent,et al.  Patent Foramen Ovale in Cryptogenic Stroke: Incidental or Pathogenic? , 2009, Stroke.

[20]  R. Sacco,et al.  Patent Foramen Ovale, Cardiac Valve Thickening, and Antiphospholipid Antibodies as Risk Factors for Subsequent Vascular Events: The PICSS-APASS Study , 2009, Stroke.

[21]  V. Pasceri,et al.  Transcathether occlusion of interatrial communications: postprocedural transoesophageal echocardiography allows timely detection and treatment of intracardiac thrombus formation. , 2009, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[22]  A. Grau,et al.  Do common prothrombotic mutations influence the risk of cerebral ischaemia in patients with patent foramen ovale? , 2009, Thrombosis and Haemostasis.

[23]  I. Palacios,et al.  Echocardiographic Assessment of Percutaneous Patent Foramen Ovale and Atrial Septal Defect Closure Complications , 2009, Circulation. Cardiovascular imaging.

[24]  J. Finsterer,et al.  Detection of paroxysmal atrial fibrillation and patent foramen ovale in cryptogenic stroke , 2009, European journal of neurology.

[25]  E. Tuzcu,et al.  Morphology of the patent foramen ovale in asymptomatic versus symptomatic (stroke or transient ischemic attack) patients. , 2009, The American journal of cardiology.

[26]  K. Chun Patent Foramen Ovale and Cryptogenic Stroke , 2008 .

[27]  J. Martí-Fàbregas,et al.  Recurrent Stroke and Massive Right-to-Left Shunt: Results From the Prospective Spanish Multicenter (CODICIA) Study , 2008, Stroke.

[28]  R. Schräder,et al.  Incidence of atrial fibrillation following transcatheter closure of atrial septal defects in adults. , 2008, The American journal of cardiology.

[29]  M. Schwerzmann,et al.  Atrial Fibrillation following Device Closure of Patent Foramen Ovale , 2008, Cardiology.

[30]  S. Windecker,et al.  Safety and feasibility of percutaneous closure of patent foramen ovale without intra-procedural echocardiography in 825 patients. , 2007, Swiss medical weekly.

[31]  Eso Writing,et al.  Guidelines for Management of Ischaemic Stroke and Transient Ischaemic Attack 2008 , 2008 .

[32]  M. Olschewski,et al.  Patent foramen ovale and cryptogenic stroke in older patients. , 2007, The New England journal of medicine.

[33]  N. Namboodiri,et al.  The 'aortic rim' recount: embolization of interatrial septal occluder into the main pulmonary artery bifurcation after atrial septal defect closure. , 2007, Interactive cardiovascular and thoracic surgery.

[34]  J. Tobis,et al.  Five-year experience with percutaneous closure of patent foramen ovale. , 2007, The American journal of cardiology.

[35]  A. Algra,et al.  Medium intensity oral anticoagulants versus aspirin after cerebral ischaemia of arterial origin (ESPRIT): a randomised controlled trial , 2007, The Lancet Neurology.

[36]  S Claiborne Johnston,et al.  Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack , 2007, The Lancet.

[37]  F. Gimigliano,et al.  Patent foramen ovale and cryptogenic stroke. A critical review , 2007, Journal of cardiovascular medicine.

[38]  M. Cheitlin Patent Foramen Ovale: Innocent or Guilty? Evidence From a Prospective Population-Based Study , 2007 .

[39]  P. McLaughlin,et al.  Transcatheter closure of aortic sinus to left atrial fistula caused by erosion of amplatzer septal occluder , 2006, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[40]  M. Kaps,et al.  Embolic Lesion Pattern in Stroke Patients With Patent Foramen Ovale Compared With Patients Lacking an Embolic Source , 2006, Stroke.

[41]  Fuad M. Kiblawi,et al.  Transcatheter closure of patent foramen ovale in older adults , 2006, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[42]  G. Anzola,et al.  Brain death worldwide: Accepted fact but no global consensus in diagnostic criteria , 2006, Neurology.

[43]  S. Kasner,et al.  PFO management: Neurologists vs cardiologists , 2005, Neurology.

[44]  M. Kaps,et al.  Identification of Embolic Stroke Patterns by Diffusion-Weighted MRI in Clinically Defined Lacunar Stroke Syndromes , 2005, Stroke.

[45]  S. Windecker,et al.  Practice parameter: recurrent stroke with patent foramen ovale and atrial septal aneurysm: report of the Quality Standards Subcommittee of the American Academy of Neurology. , 2018, Neurology.

[46]  J. Cheatham,et al.  Erosion of Amplatzer septal occluder device after closure of secundum atrial septal defects: Review of registry of complications and recommendations to minimize future risk , 2004, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[47]  R. Schräder Incidence and clinical course of thrombus formation on atrial septal defect and patent foramen ovale closure devices. , 2004, Journal of the American College of Cardiology.

[48]  P. Block,et al.  Transcatheter patent foramen ovale closure for secondary prevention of paradoxical embolic events: Acute results from the FORECAST registry , 2004, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[49]  A. Kelion,et al.  Transthoracic echocardiography using second harmonic imaging with Valsalva manoeuvre for the detection of right to left shunts. , 2004, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[50]  M. Zennaro,et al.  Transcatheter atrial septal defect closure assisted by intracardiac echocardiography: 3-year follow-up. , 2004, Journal of interventional cardiology.

[51]  R. Sacco,et al.  Classification of Ischemic Stroke , 2004 .

[52]  E. Foster,et al.  Harmonic Imaging Improves Sensitivity at the Expense of Specificity in the Detection of Patent Foramen Ovale , 2004, Echocardiography.

[53]  Paul Khairy,et al.  Transcatheter Closure versus Medical Therapy of Patent Foramen Ovale and Presumed Paradoxical Thromboemboli , 2003, Annals of Internal Medicine.

[54]  G. Anzola,et al.  Transcranial Doppler and risk of recurrence in patients with stroke and patent foramen ovale , 2003, European journal of neurology.

[55]  J. Mas Patent Foramen Ovale and Stroke , 2003, Practical Neurology.

[56]  G. Anzola,et al.  Patent foramen ovale with paradoxical embolism: mid-term results of transcatheter closure in 256 patients. , 2003, Journal of interventional cardiology.

[57]  S. Ho,et al.  Morphological features pertinent to interventional closure of patent oval foramen. , 2003, Journal of interventional cardiology.

[58]  D. Darby,et al.  Examining the Lacunar Hypothesis With Diffusion and Perfusion Magnetic Resonance Imaging , 2002, Stroke.

[59]  R. Sacco,et al.  Effect of Medical Treatment in Stroke Patients With Patent Foramen Ovale: Patent Foramen Ovale in Cryptogenic Stroke Study , 2002, Circulation.

[60]  R. Sacco,et al.  Antithrombotic and thrombolytic therapy for ischemic stroke. , 2001, Chest.

[61]  J. Coste,et al.  Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. , 2001, The New England journal of medicine.

[62]  K. Furie,et al.  A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. , 2001, The New England journal of medicine.

[63]  H. Schuchlenz,et al.  Catheter closure of the persistent foramen ovale: mid-term results in 162 patients. , 2001, Journal of interventional cardiology.

[64]  I. Bone,et al.  Interatrial septal abnormalities and stroke , 2000, Neurology.

[65]  Z. Yiğit,et al.  Atrial Septal Aneurysm in Adult Patients , 1999 .

[66]  D. Tanné,et al.  Anticardiolipin antibodies and their associations with cerebrovascular risk factors , 1999, Neurology.

[67]  P. Penther [Patent foramen ovale: an anatomical study. Apropos of 500 consecutive autopsies]. , 1994, Archives des maladies du coeur et des vaisseaux.

[68]  David Lee Gordon,et al.  Classification of Subtype of Acute Ischemic Stroke: Definitions for Use in a Multicenter Clinical Trial , 1993, Stroke.

[69]  J. Newburger,et al.  Transcatheter Closure of Patent Foramen Ovale After Presumed Paradoxical Embolism , 1992, Circulation.

[70]  Daniel B Hier,et al.  Infarcts of undetermined cause: The NINCDS stroke data bank , 1989, Annals of neurology.

[71]  H. J. Smith,et al.  PATENT FORAMEN OVALE IN YOUNG STROKE PATIENTS , 1988, The Lancet.